The Nanomedicines Alliance focuses on the global advancement of nanomedicines from research to commercialization.
The Nanomedicines Alliance is the only industry group in existence that focuses on the scientific and regulatory aspects and policy needs of nanomedicines.
The Nanomedicines Alliance currently focuses on standard-setting, particle size analysis, and strengthening its relationship with FDA and other global regulatory agencies. The Alliance also actively organizes conference sessions and panels on nanomedicines.
The Nanomedicines Alliance publishes white papers and gives presentations on nanotechnology developments and regulatory considerations. The Alliance also publishes a free regular newsletter, the NanoMed Digest.
Consider joining the Nanomedicines Alliance to advance the global research and development of nanomedicines, to influence regulation, and to be a voice for innovation in industry. Contact us today about membership.
Sign up for our free newsletter, the NanoMed Digest. Past issues of the NanoMed Digest are also available here.